Professor of Paediatric Haematology, University of Oxford
Professor of Bioinformatics, Barts Cancer Institute, Queen Mary University of London
Patient affiliate
Patient affiliate
Director, National Quantum Computing Centre
Professor of AI in Radiation Oncology, University of Cambridge Department of Oncology and Cambridge University Hospitals
Patient affiliate
Senior Vice President and Head of Oncology Translational Research, GSK
09:00–10:00 | Registration, networking and poster set-up |
10:00–10:20 | Welcome Catherine Elliot, Cancer Research UK |
10:25–11:00 | Opening keynote Michael Cuthbert, UK National Quantum Computing Centre |
11:00–11:30 | Networking break |
11:30–12:40 | Emerging technologies for cancer research: spotlight on quantum Chair: Michael Cuthbert, UK National Quantum Computing Centre Speakers: Chris Phillips, Imperial College London |
12:40–13:40 | Lunch and posters |
13:40–14:40 | Panel: Driving the next era of cancer research: data and collaborative innovation |
14:45–15:05 | Introduction to the CRUK Data Community Special Interest Groups |
15:05–15:35 | Networking break |
15:35–16:35 | Roundtable sessions: what will the next five years of data driven cancer research look like? |
16:40–17:25 | Closing keynote |
17:25–1730 | Closing remarks Melissa Lewis-Brown, Cancer Research UK |
17:30–18:30 | Drinks and networking reception |
08:30–09:00 | Registration and networking |
09:00–09:10 | Welcome back Melissa Lewis-Brown, Cancer Research UK |
09:15–09:45 | Keynote: Why children are key to responsible AI Mhairi Aitken, Turing Institute |
09:50–10:35 | Session 3: AI-enabled target/drug discovery Chair: Greg Hannon, Cambridge Cancer Institute Speakers: Diego Oyarzun, The University of Edinburgh |
10:35–11:05 | Networking break |
11:05–12:30 | Session 4: AI-accelerated early detection of cancer using imaging and multimodal data Chair: Raj Jena, University of Cambridge Speakers: Jacqui Shaw, University of Leicester Heba Sailam, King’s College London Konstantinos Zormpas-Petridis, Agostino Gemelli University Policlinic |
12:30–13:30 | Lunch and posters |
13:30–14:35 | Great Debate 2: AI in population genomics is more hype than help Chair: Richard Lee, The Royal Marsden and Institute of Cancer Research Early Diagnosis and Detection Centre Speakers: Kiley Graim, University of Florida Montse Garcia-Closas, Institute of Cancer Research |
14:30–15:00 | Networking break |
15:00–16:05 | Session 5: Advances in AI and computation in personalised radiation therapy Chair: Bill Nailon, University of Edinburgh Speakers: David Noble, Edinburgh Cancer Centre Marianne Aznar, University of Manchester Andre Dekker, Maastricht University |
16:10–16:50 | Closing keynote: Agent AI and the future of drug discovery and development Bissan Al-Lazikani, MD Anderson Cancer Centre |
16:50–16:55 | Closing remarks Melissa Lewis-Brown, Cancer Research UK |
17:00–19:00 | Networking drinks reception (with bowl food) |
08:30–09:00 | Registration |
09:00–09:10 | Welcome back |
09:10–09:50 | Keynote: Why data matters: enabling large scale population health research in the UK in the 'big data' era Cathie Sudlow, University of Edinburgh |
09:55–10:20 | Flash talks on the power of health data in personalised medicine Chair: Cathie Sudlow, University of Edinburgh |
10:20–10:50 | Networking break |
10:50–12:15 | Session 6: Transforming medicine through digital twins Chair: Tony Ng, GSK and King's College London Speakers: Walter Kolch, Systems Biology Ireland, University College Dublin Lena Granovsky, GSK Jasmin Fisher, UCL Cancer Institute |
12:15–13:45 | Lunch and posters |
13:45–14:45 | Panel: balancing promise and risk - how do we best regulate digital twins and personalised medicine? Chair: Mark Lawler, Queens University Belfast Speakers: Angela Aristidou, UCL/Stanford Irina Babina, Concr |
14:45–15:15 | Networking break |
15:15–16:05 | Is personalised medicine accessible to all? Biases and opportunities for diverse groups of patients Chair: Melissa Davis, Morehouse School of Medicine Speakers: Anna Schuh, University of Oxford |
16:10–16:40 | Closing keynote: From bias to breakthroughs: making precision medicine truly inclusive Melissa Davis, Morehouse School of Medicine |
16:45–16:55 | Closing remarks |
Director of the Usher Institute, School of Population Health Sciences, The University of Edinburgh and Director of the UKRI Adolescent Health Study
Why data matters: Enabling large scale population health research in the UK in the 'big data' era
Senior Ethics Fellow, The Alan Turing Institute
Why children are key to responsible AI
Director, Institute of Translational Genomic Medicine, Morehouse School of Medicine
From bias to breakthroughs: making precision medicine truly inclusive
Professor of Genomic Medicine and Director of Therapeutics Data Science, Department of Genomic Medicine, MD Anderson Cancer Centre
Senior Group Leader, Cancer Research UK Cambridge Institute
Day 2 - Revolutionising cancer research: the transformative role of AI
Professor of AI in Radiation Oncology, University of Cambridge Department of Oncology and Cambridge University Hospitals
Day 2 - Revolutionising cancer research: the transformative role of AI
Consultant Respiratory Physician, NIHR Biomedical Research Centre at The Royal Marsden and the Institute of Cancer Research
Day 2 - Revolutionising cancer research: the transformative role of AI
NHS Clinical Scientist
Professor, Department of Oncology Physics at the Edinburgh Cancer Centre
Day 2 - Revolutionising cancer research: the transformative role of AI
Director, Institute of Translational Genomic Medicine, Morehouse School of Medicine
Day 3 - Personalising cancer medicine: the power of health data
Senior Vice President and Head of Oncology Translational Research, GSK
Day 3 - Personalising cancer medicine: the power of health data
Professor of Digital Health, Queen’s University Belfast
Scientific Director, DATA-CAN
Day 3 - Personalising cancer medicine: the power of health data
